Determination of Affinity and Activity of Ligands at the Human Neuropeptide Y Y₄ Receptor by Flow Cytometry and Aequorin Luminescence

REFERENCES

• von Horsten S, Hoffmann T, Alfalah M, Wrann C D, Karl T, Pabst R, Bedoui S. PP, PYY and NPY: Synthesis, storage, release and degradation. Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology 162, M C Michel. Springer, Berlin, Heidelberg, New York 2004; 23–44
   Google Scholar
• Cox H M. Peptidergic regulation of intestinal ion transport. A major role for neuropeptide Y and the pancreatic polypeptides. Digestion 1998; 59: 395–399
   Google Scholar
• Schwartz T W. Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 1983; 85: 1411–1425
   PubMed Web of Science ®Google Scholar
• Hazelwood R L. The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 1993; 202: 44–63
   PubMed Web of Science ®Google Scholar
• Feletou M, Nicolas J P, Rodriguez M, Beauverger P, Galizzi J P, Boutin J A, Duhault J. NPY receptor subtype in the rabbit isolated ileum. Br J Pharmacol 1999; 127: 795–801
   Google Scholar
• Pheng L H, Perron A, Quirion R, Cadieux A, Fauchere J L, Dumont Y, Regoli D. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon. Eur J Pharmacol 1999; 374: 85–91
   PubMedGoogle Scholar
• Campbell R E, Smith M S, Allen S E, Grayson B E, Ffrench-Mullen J M, Grove K L. Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 2003; 23: 1487–1497
   PubMedGoogle Scholar
• Clark J T, Kalra P S, Crowley W R, Kalra S P, Neuropeptide Y. and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984; 115: 427–429
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Ueno N, Fujimiya M, Fujino M A, Kasuga M. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 1999; 20: 1445–1448
   PubMed Web of Science ®Google Scholar
• Katsuura G, Asakawa A, Inui A. Roles of pancreatic polypeptide in regulation of food intake. Peptides 2002; 23: 323–329
   PubMed Web of Science ®Google Scholar
• Inui A, Okita M, Nakajima M, Inoue T, Sakatani N, Oya M, Morioka H, Okimura Y, Chihara K, Baba S. Neuropeptide regulation of feeding in dogs. Am J Physiol 1991; 261: R588–594
   PubMedGoogle Scholar
• Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino M A, Niijima A, Meguid M M, Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003; 124: 1325–1336
   PubMed Web of Science ®Google Scholar
• Moran T H. Pancreatic polypeptide: more than just another gut hormone?. Gastroenterology 2003; 124: 1542–1544
   Google Scholar
• Batterham R L, Le Roux C W, Cohen M A, Park A J, Ellis S M, Patterson M, Frost G S, Ghatei M A, Bloom S R. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003; 88: 3989–3992
   PubMed Web of Science ®Google Scholar
• Michel M C, Beck-Sickinger A, Cox H, Doods H N, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 1998; 50: 143–150
   PubMed Web of Science ®Google Scholar
• Walker M W, Smith K E, Bard J, Vaysse P J, Gerald C, Daouti S, Weinshank R L, Branchek T A. A structure-activity analysis of the cloned rat and human Y4 receptors for pancreatic polypeptide. Peptides 1997; 18: 609–612
   Google Scholar
• Yan H, Yang J, Marasco J, Yamaguchi K, Brenner S, Collins F, Karbon W. Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. Proc Natl Acad Sci USA 1996; 93: 4661–4665
   Google Scholar
• Berglund M M, Lundell I, Eriksson H, Soll R, Beck-Sickinger A G, Larhammar D. Studies of the human, rat, and guinea pig Y4 receptors using neuropeptide Y analogues and two distinct radioligands. Peptides 2001; 22: 351–356
   Google Scholar
• Eriksson H, Berglund M M, Holmberg S K, Kahl U, Gehlert D R, Larhammar D. The cloned guinea pig pancreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4. Regul Pept 1998; 75–76: 29–37
   Google Scholar
• Parker M S, Lundell I, Parker S L. Pancreatic polypeptide receptors: Affinity, sodium sensitivity and stability of agonist binding. Peptides 2002; 23: 291–303
   Google Scholar
• Parker M S, Sah R, Sheriff S, Balasubramaniam A, Parker S L. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists. Regul Pept 2005; 132: 91–101
   Google Scholar
• Dumont Y, Quirion R. [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors. Br J Pharmacol 2000; 129: 37–46
   Google Scholar
• Dautzenberg F M, Higelin J, Pflieger P, Neidhart W, Guba W. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist. Neuropharmacology 2005; 48: 1043–1055
   Google Scholar
• Gehlert D R, Schober D A, Gackenheimer S L, Beavers L, Gadski R, Lundell I, Larhammar D. [125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: Evidence for heterogeneity in pancreatic polypeptide receptors. Peptides 1997; 18: 397–401
   PubMed Web of Science ®Google Scholar
• Schneider E, Mayer M, Ziemek R, Li L, Hutzler C, Bernhardt G, Buschauer A. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes. ChemBioChem 2006; 7: 1400–1409
   Google Scholar
• Ziemek R, Brennauer A, Schneider E, Cabrele C, Beck-Sickinger A G, Bernhardt G, Buschauer A. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands. Eur J Pharmacol 2006; 551: 10–18
   Google Scholar
• Lundell I, Blomqvist A G, Berglund M M, Schober D A, Johnson D, Statnick M A, Gadski R A, Gehlert D R, Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 1995; 270: 29123–29128
   PubMed Web of Science ®Google Scholar
• Voisin T, Goumain M, Lorinet A M, Maoret J J, Laburthe M. Functional and molecular properties of the human recombinant Y4 receptor: Resistance to agonist-promoted desensitization. J Pharmacol Exp Ther 2000; 292: 638–646
   Google Scholar
• Coward P, Chan S DH, Wada H G, Humphries G M, Conklin B R. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal Biochem 1999; 270: 242–248
   PubMed Web of Science ®Google Scholar
• Stables J, Green A, Marshall F, Fraser N, Knight E, Sautel M, Milligan G, Lee M, Rees S. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem 1997; 252: 115–126
   PubMed Web of Science ®Google Scholar
• Ungrin M D, Singh L M, Stocco R, Sas D E, Abramovitz M. An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors. Anal Biochem 1999; 272: 34–42
   PubMed Web of Science ®Google Scholar
• Dupriez V J, Maes K, Le Poul E, Burgeon E, Detheux M. Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. Receptors Channels 2002; 8: 319–330
   PubMedGoogle Scholar
• Knight P J, Grigliatti T A, Chimeric G. proteins extend the range of insect cell-based functional assays for human G protein-coupled receptors. J Recept Signal Transduct Res 2004; 24: 241–256
   PubMed Web of Science ®Google Scholar
• Kostenis E. Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?. Trends Pharmacol Sci 2001; 22: 560–564
   PubMed Web of Science ®Google Scholar
• Balasubramaniam A, Dhawan V C, Mullins D E, Chance W T, Sheriff S, Guzzi M, Prabhakaran M, Parker E M. Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro30, Tyr32, Leu34]NPY(28-36)-NH2 (BW1911U90). J Med Chem 2001; 44: 1479–1482
   PubMedGoogle Scholar
• Cabrele C, Wieland H A, Langer M, Stidsen C E, Beck-Sickinger A G. Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides 2001; 22: 365–378
   Google Scholar
• Ghorai P. Arpromidine-Related Acylguanidines: Synthesis and Structure-Activity Relationships of a New Class of Guanidine-Type Histamine H₂ Receptor Agonists with Reduced Basicity. Doctoral thesis, University of Regensburg, Germany 2005, http://www.opus-bayern.de/uni-regensburg/volltexte/2006/561/
   Google Scholar
• Cheng Y, Prusoff W H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099–3108
   PubMed Web of Science ®Google Scholar
• Müller M, Knieps S, Gessele K, Dove S, Bernhardt G, Buschauer A. Synthesis and neuropeptide Y Y1 receptor antagonistic activity of N,N-disubstituted ω -guanidino- and ω -aminoalkanoic acid amides. Arch Pharm (Weinheim) 1997; 330: 333–342
   Google Scholar
• Gehlert D R, Schober D A, Beavers L, Gadski R, Hoffman J A, Smiley D L, Chance R E, Lundell I, Larhammar D. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol 1996; 50: 112–118
   PubMed Web of Science ®Google Scholar
• Parker M S, Berglund M M, Lundell I, Parker S L. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport. Implications for receptor signaling and regulation. Peptides 2001; 22: 887–898
   Google Scholar
• Schober D A, Gackenheimer S L, Heiman M L, Gehlert D R. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/peptide YY receptors. J Pharmacol Exp Ther 2000; 293: 275–280
   Google Scholar
• Carreras C W, Siani M A, Santi D V, Dillon S B. Stable expression of a synthetic gene for the human motilin receptor: Use in an aequorin-based receptor activation assay. Anal Biochem 2002; 300: 146–151
   Google Scholar
• George S E, Schaeffer M T, Cully D, Beer M S, McAllister G. A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels. Anal Biochem 2000; 286: 231–237
   Google Scholar
• Janecka A, Poels J, Fichna J, Studzian K, Vanden Broeck J. Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay. Regul Pept 2005; 131: 23–28
   Google Scholar
• Knight P JK, Pfeifer T A, Grigliatti T A. A functional assay for G-protein-coupled receptors using stably transformed insect tissue culture cell lines. Anal Biochem 2003; 320: 88–103
   PubMedGoogle Scholar
• Le Poul E, Hisada S, Mizuguchi Y, Dupriez V J, Burgeon E, Detheux M. Adaptation of aequorin functional assay to high throughput screening. J Biomol Screen 2002; 7: 57–65
   PubMedGoogle Scholar
• Torfs H, Detheux M, Oonk H B, Akerman K E, Poels J, Loy T V, Loof A D, Vassart G, Parmentier M, Broeck J V. Analysis of C-terminally substituted tachykinin-like peptide agonists by means of aequorin-based luminescent assays for human and insect neurokinin receptors. Biochem Pharmacol 2002; 63: 1675–1682
   Google Scholar
• Conklin B R, Farfel Z, Lustig K D, Julius D, Bourne H R. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα. Nature 1993; 363: 274–276
   PubMed Web of Science ®Google Scholar
• Schober D A, Van Abbema A M, Smiley D L, Bruns R F, Gehlert D R. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor. Peptides 1998; 19: 537–542
   Google Scholar
• Parker E M, Babij C K, Balasubramaniam A, Burrier R E, Guzzi M, Hamud F, Mukhopadhyay G, Rudinski M S, Tao Z, Tice M, Xia L, Mullins D E, Salisbury B G. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur J Pharmacol 1998; 349: 97–105
   PubMedGoogle Scholar
• Cox H M, Tough I R, Zandvliet D W, Holliday N D. Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines. Br J Pharmacol 2001; 132: 345–353
   Google Scholar
• Berglund M M, Schober D A, Statnick M A, McDonald P H, Gehlert D R. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction. J Pharmacol Exp Ther 2003; 306: 147–156
   Google Scholar
• Berglund M M, Schober D A, Esterman M A, Gehlert D R. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 2003; 307: 1120–1126
   PubMedGoogle Scholar